Danish pharmaceutical giant Novo Nordisk has announced major investment in a French production site to expand the capacity and manufacturing of its blockbuster anti-obesity drug.
Danish pharmaceutical invests €2.1 billion in France
On Thursday, Danish pharmaceutical giant Novo Nordisk announced a major investment in a French production site to expand the..
euronews (in English)